| ［1］ |
Mc Cullough PA.Contrast-induced acute kidney injury［J］.J Am Coll Cardiol，2008，51（15）：1419-1428.
|
| ［3］ |
Krummel T，Faller AL，Bazin D，et al.Contrast-induced nephropathy［J］.Presse Med，2010，39（7-8）：807-814.
|
| ［5］ |
Khaja A.KDIGO clinical practice guidelines for acute kidney injury［J］.Nephron Clin Pract，2012，120（4）：179-184.
|
| ［11］ |
马雪，张蓓茹，李德天.尿KIM-1蛋白诊断早期造影剂肾病的实验研究［J］.南方医科大学学报，2011，31（2）：357-360.
|
| ［2］ |
Solomon R，Mehran R，Natarajan M，et al.Contrast-induced nephropathy and long-term adverse events：cause and effect［J］.Clin J Am Soc Nephrol，2009，4（7）：1162-1169.
|
| ［4］ |
Stacul F，Van Der Molen AJ，Reimer P，et al.Contrast induced nephropathy：updated ESUR Contrast Media Safety Committee guidelines［J］.Eur Radiol，2011，21（12）：2527-2541.
|
| ［6］ |
McCullough PA，Adam A，Becker CR，et al.Risk prediction of contrast-induced nephropathy［J］.Am J Cardiol，2006，98 （6 Suppl 1）：27-36.
|
| ［7］ |
Ichimura T，Bonventre JV，Bailly V，et al.Kidney injury molecule-1（KIM-1），a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain，is upregulated in renal cells after injury［J］.J Biol Chem，1998，273（7）：4135-4142.
|
| ［8］ |
Zhang Z，Humphreys BD，Boruentre JV.Shedding of the urinary biomarkei kidney injury molecule-1（KIM-1）is regulated by MAP kinases and juxtamembrane region［J］.J Am Soc Nephrol，2007，18（10）：2701.
|
| ［9］ |
Bailly V，Zhang Z，Meier W，et al.Shedding of kidney injury molecule-1，a putative adhesion protein involved in renal regeneration［J］.J Biol Chem，2002，277（42）：39739-39748.
|
| ［10］ |
Cárdenas-González MC，Del Razo LM，Barrera-Chimal J，et al.Proximal renal tubular injury in rats sub-chronically exposed to low fluoride concentrations［J］.Toxicol Appl Pharmacol，2013，272（3）：888-894.
|
| ［12］ |
Han WK，aikar SS，Johnson A，et al.Urinary biomarkers in the early diagnosis of acute kidney injury［J］.Kidney Int，2008，73（7）：863-869.
|
| ［13］ |
Vlasakova K，Erdos Z，Troth SP，et al.Evaluation of the relative performance of 12 urinary biomarkers for renal safety across 22 rat sensitivity and specificity studies［J］. Toxicol Sci，2014，138（1）：3-20.
|
| ［14］ |
Dieterle F，Sistare F，Goodsaid F，et al.Renal biomarker qualification submission：a dialog between the FDA-EMEA and Predictive Safety Testing Consortium［J］.Nat Biotechnol，2010，28（5）：455-462.
|
| ［15］ |
Kjeldsen L，Johsen AH，Sengelov H，et al.Isolation and primary structure of NGAL，a novel protein associated with human neutrophil gelatinase［J］.J Biol Chem，1993，268 （14）：10425-10432.
|
| ［16］ |
Mishra J，Ma Q，Prada A，et al.Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury［J］.J Am Soc Nephrol，2003，14（10）：2534.
|
| ［17］ |
Mishra J，Mori K，Ma Q，et al.Neutrophil gelatinase-associated lipocalin：a novel early urinary biomarker for cisplatin nephrotoxicity［J］.Am J Nephrol，2004，24（3）：307-315.
|
| ［18］ |
Vassilis F，Dimitra B，Dimitrios L，et al.Plasma neutrophil gelatinase-associated lipocalin（NGAL）as an early predictive marker of contrast-induced nephropathy in hospitalized patients undergoing computed tomography［J］. Clin Kidney J，2013，6（6）：578-583.
|
| ［19］ |
Holzscheiter L，Beck C，Rutz S，et al.NGAL，L -FABP，andKIM-1 in comparison to established markers of renal dysfunction［J］.Clin Chem Lab Med，2014，52（4）：537-546.
|
| ［20］ |
Melnikov VY，Ecder T，Fantuzzi G，et al.Impaired IL-18 processingprotectscaspase-1-deficientmicefromischemic acute renal failure［J］.J Clin Invest，2001，107（9）：1145.
|
| ［21］ |
Ling W，Zhaohui N，Ben H，et al.Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography［J］.Nephron Clin Pract，2008，108（3）：176-181.
|
| ［22］ |
Parikh CR，Mishra J，Thiessen-Philbrook H，et al.Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery［J］.Kidney Int，2006，70（1）：199.
|
| ［23］ |
Bulent Gul CB，Gullulu M，Oral B，et al.Urinary IL-18：A marker of contrast-induced nephropathy following percutaneous coronary intervention［J］.Clin Biochem，2008，41 （7-8）：544-547.
|
| ［32］ |
Vaidya VS，Ferguson MA，Bonventre JV.Biomarkers of acute kidney injury［J］.Annu Rev Pharmacol Toxicol，2008，48：463-493.
|
| ［24］ |
Kamijo-Ikemori A，Sugaya T，Kimura K.Urinary fatty acid binding protein in renal disease［J］.Clin Chim Acta，2006，374（1-2）：1-7.
|
| ［25］ |
Ohta S，Ishimitsu T，Minami J，et al.Effects of intravascular contrast media on urinary excretion of liver fatty acidbinding protein［J］.Nippon Jinzo Gakkai Shi，2005，47（4）：437-444.
|
| ［26］ |
Nakamura T，Sugaya T，Node K，et al.Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy［J］.Am J Kidney Dis，2006，47 （1）：439-444.
|
| ［27］ |
Kato K，Sato N，Yamamoto T，et al.Valuable markers for contrastinduced nephropathy in patients undergoing cardiac catheterization［J］.Circ J，2008，72（9）：1499-1505.
|
| ［28］ |
Bachorzewska-Gajewska H，Poniatowski B，Dobrzycki S. NGAL（neutrophil gelatinase-associated lipocalin）and L-FABP after percutaneous coronary interventions due to unstable angina in patients with normal serum creatinine ［J］.Adv Med Sci，2009，54（2）：221-224.
|
| ［29］ |
Von Eynatten M，Baumann M，Heemann U.Urinary L-FABP and anaemia：distinct roles of urinary markers in type-diabetes［J］.Eur J Clin Invest，2010，40（2）：95-102.
|
| ［30］ |
Holzscheiter L，Beck C，Rutz S，et al.NGAL，L-FABP，and KIM -1 in comparison to established markers of renal dysfunction［J］.Clin Chem Lab Med，2014，52（4）：537-546.
|
| ［31］ |
Perry TE，Muehlschlegel JD，Liu KY，etal.Plasma neutrophil gelatinase -associated lipocalin and acute postoperative kidney injury in adult cardiac surgical patients［J］.Anesth Analg，2010，110（6）：1541-1547.
|
